Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2317 of 6351
-
New HPV vaccine aims to block more cancer types in early trial
Vaccine OngoingResearchers are looking for new ways to prevent cancers related to human papillomavirus (HPV). HPV is a common virus that can cause an infection. There are many different types of HPV. Most people's immune system can fight HPV infection and it goes away without treatment. For som…
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Vaccine
Last updated Jun 27, 2026 11:01 UTC
-
New tool aims to slash months-long thyroid dose adjustment to weeks
Symptom relief Recruiting nowLevothyroxine is the most used thyroid hormone replacement when the thyroid gland is failing. Because dosage adjustment normally takes several months, the investigators have developed a decision support tool (DST) that predicts optimal dosage based on repeated blood samples the f…
Sponsor: University Hospital of North Norway • Aim: Symptom relief
Last updated Jun 26, 2026 16:45 UTC
-
New bladder cancer drug shows promise in early trial
Disease control Recruiting nowThe goal of the study is to learn about the safety of Sacituzumab Tirumotecan and if people can tolerate it when given in the bladder and find the highest dose that people can take without having certain problems. Researchers will then choose a dose level of Sacituzumab Tirumotec…
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Heart attack recovery: could Lower-Dose statins be just as good?
Disease control CompletedThis study evaluates the effectiveness of high- and moderate-intensity statins in achieving target low-density lipoprotein cholesterol (LDL-C) levels in patients with acute coronary syndrome (ACS). The study aims to determine whether moderate-intensity statins can provide compara…
Sponsor: Khyber Medical University Peshawar • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New gel could treat painful skin vein bumps
Disease control OngoingA Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX022 (sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations
Phase 2 • Sponsor: Palvella Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Which archwire sequence straightens teeth faster and hurts less?
Knowledge-focused CompletedIn this Clinical trial we aim to compare alignment speed, patient discomfort and root resorption between two different sequences of NiTi archwires
Sponsor: Foundation University Islamabad • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Brain stimulation trial targets depression in autism
Symptom relief Recruiting nowDepression is a common complication of Autism Spectrum Disorder (ASD): it is four times more prevalent in people with ASD than in the general population. However, treating depression in people with ASD is complicated by the lack of guidelines. Antidepressants appear to be less e…
Sponsor: Hospital Center Guillaume Régnier • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New lens aims to sharpen vision at all distances after cataract surgery
Disease control Recruiting nowThe study purpose is to demonstrate safety and performance of bilateral implantation of LuxHighAdd intraocular lens compared with the LuxGood Monofocal lens.
Sponsor: Cutting Edge SAS • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a stiffer prosthetic foot help you keep your balance?
Symptom relief CompletedThe goal of this clinical trial is to identify prosthesis stiffness that optimizes balance control in individuals with below knee amputations. The main question this clinical trial will answer is: • Is there an optimal stiffness that improves balance control for specific ambulat…
Sponsor: Seattle Institute for Biomedical and Clinical Research • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
New heart lead aims to improve pacing for slow heartbeat
Disease control CompletedThe purpose of the BIO-CONDUCT study is to demonstrate the safety and effectiveness of the BIOTRONIK Solia CSP S pacing lead when implanted in the left bundle branch area (LBBA). Safety will be assessed by evaluating serious adverse device effects that occur through 3 months post…
Sponsor: Biotronik, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New hope for leukemia patients? early trial launches
Disease control Recruiting nowEvaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ICP-248 in combination with azacitidine in patients with acute myelogenous leukemia and Myelodysplastic Syndromes.
Phase 1 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Lifestyle coaching after kidney transplant may curb weight gain and diabetes risk
Disease control Recruiting nowThe goal of this clinical trial is to learn whether if it is feasible to implement a study of patients receiving kidney transplantation, to learn if these patients will complete selective outcomes measurements, and to examine if a lifestyle intervention may assist with preventing…
Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New lung device trial aims to seal troubled vessels
Disease control Recruiting nowThe goal of this clinical trial is to evaluate both the technical success and efficacy of using the LOBO™ device in patients undergoing embolization of Pulmonary Arteriovenous Malformations (PAVM). The main question\[s\] it aims to answer \[is/are\]: * What is the technical succ…
Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Blood antibodies may predict heart failure risk after viral infection
Knowledge-focused Recruiting nowBackground of the study Studies have shown that about one-third of patients with acute viral myocarditis (AVMC) eventually develop dilated cardiomyopathy (DCM), and that the autoimmune response to viral infection is key to the development of AVMC to DCM. A variety of antimyocardi…
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Skin test could reveal Parkinson's progression
Knowledge-focused OngoingThis study aims to assess the levels of phosphorylated alpha-synuclein (P-SYN) in patients with Parkinson's disease and REM Behavior Disorder using a minimally invasive skin punch biopsy. It seeks to understand the natural progression of P-SYN deposition over time to explore the …
Sponsor: CND Life Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Balloon vs stent: which works best for Rock-Hard heart plaques?
Disease control Recruiting nowInternational, investigator-driven, multicenter, open-label, prospective randomized controlled trial where patients with de novo lesions due to calcified nodules (CN) were randomized to drug eluting balloon (DEB) or drug eluting stents (DES).
Sponsor: Fundación EPIC • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Generic psoriasis cream could offer cheaper alternative to VTAMA®
Disease control CompletedTo compare the safety and efficacy of the test (Tapinarof Cream 1%), placebo (vehicle cream) and reference VTAMA® (Tapinarof Cream 1%) treatments to demonstrate clinical equivalence in patients with plaque psoriasis.
Phase 3 • Sponsor: Teva Pharmaceuticals USA • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Your smartwatch might spot sleep apnea!
Diagnosis CompletedThe study will test the reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea (OSA)
Sponsor: Stanford University • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
New hope for sinus sufferers: drug targets stubborn inflammation
Symptom relief CompletedACT18421 is a multinational, randomized, double-blind, placebo-controlled, parallel-group, Phase 2 study with 3 treatment groups. The purpose of the study is to evaluate the efficacy, safety and tolerability of 2 dosing regimens of itepekimab compared to placebo in male and femal…
Phase 2 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Brain zaps may steady Parkinson's patients
Symptom relief CompletedThis study aimed to investigate the effects of rTMS on balance performance and functional mobility in people with PD. Additionally, it further examines the effects of single-session low-frequency and high-frequency repetitive transcranial magnetic stimulation on balance performan…
Sponsor: Chung Shan Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC